Clinical observation of Gushen antai pill combined with heparin sodium in the treatment of anticardiolipin antibody-positive recurrent abortion

ZHANG Li; DONG Bingying; YUAN Xiaoli

doi:10.6039/j.issn.1001-0408.2023.07.18

您当前的位置：

首页 >

文章列表页 >

Clinical observation of Gushen antai pill combined with heparin sodium in the treatment of anticardiolipin antibody-positive recurrent abortion

更新时间：2024-02-19

- Clinical observation of Gushen antai pill combined with heparin sodium in the treatment of anticardiolipin antibody-positive recurrent abortion
- ZHONGGUO YAOFANG Vol. 34, Issue 7, Pages: 863-867(2023)
- 作者机构：
  
  三二〇一医院妇科，陕西汉中　723000
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2023.07.18
  CLC： R984
- Published：15 April 2023，
  
  Received：20 November 2022，
  
  Revised：27 February 2023，
扫描看全文
张丽,董冰莹,袁小丽.固肾安胎丸联合达肝素钠治疗ACA阳性复发性流产的临床观察 ^Δ[J].中国药房,2023,34(07):863-867.

ZHANG Li,DONG Bingying,YUAN Xiaoli.Clinical observation of Gushen antai pill combined with heparin sodium in the treatment of anticardiolipin antibody-positive recurrent abortion[J].ZHONGGUO YAOFANG,2023,34(07):863-867.
张丽,董冰莹,袁小丽.固肾安胎丸联合达肝素钠治疗ACA阳性复发性流产的临床观察 ^Δ[J].中国药房,2023,34(07):863-867. DOI： 10.6039/j.issn.1001-0408.2023.07.18.

ZHANG Li,DONG Bingying,YUAN Xiaoli.Clinical observation of Gushen antai pill combined with heparin sodium in the treatment of anticardiolipin antibody-positive recurrent abortion[J].ZHONGGUO YAOFANG,2023,34(07):863-867. DOI： 10.6039/j.issn.1001-0408.2023.07.18.

摘要

目的

探讨固肾安胎丸联合达肝素钠对抗心磷脂抗体（ACA）阳性复发性流产患者的临床疗效。

方法

将ACA阳性复发性流产患者203例随机分为对照组（

＝101）和联合治疗组（

＝102）。对照组患者在基础治疗的基础上采用达肝素钠治疗，联合治疗组患者在对照组治疗的基础上加用固肾安胎丸治疗。收集患者血清样本，采用酶联免疫吸附试验法检测2组患者血清白细胞介素6（IL-6）、肿瘤坏死因子α（TNF-α）、环氧化酶2（COX-2）、

人绒毛膜促性腺激素（

-HCG）、ACA 水平并计算抗体转阴率，观察患者的临床疗效，同时记录不良反应发生情况。

结果

治疗后，联合治疗组患者的妊娠成功率和抗体转阴率均显著高于对照组（

＜0.05），流产率显著低于对照组（

＜0.05）；2组患者血清IL-6、TNF-α、ACA水平均较治疗前显著下降（

＜0.05），COX-2、

- HCG水平均较治疗前显著升高（

＜0.05），且联合治疗组患者上述指标水平变化更显著（

＜0.05）。2组患者不良反应发生率比较，差异无统计学意义（

＞0.05）。

结论

固肾安胎丸可通过上调ACA阳性复发性流产患者血清COX-2水平、下调IL-6水平来维持

-HCG的高表达，降低ACA水平，改善免疫微环境，从而提高妊娠成功率。

Abstract

OBJECTIVE

To investigate the clinical efficacy of Gushen antai pills combined with heparin sodium in the treatment of antiphospholipin antibody （ACA）-positive recurrent abortion.

METHODS

A total of 203 ACA-positive recurrent abortion patients were randomly divided into control group （

＝101） and combination treatment group （

＝102）. Control group was additionally treated with heparin sodium on basis of basic treatment， and combination treatment group was additionally treated with Gushen antai pills on the basis of control group. Serum samples were collected from patients， the levels of interleukin 6 （IL-6）， tumor necrosis factor α （TNF-α）， cyclooxygenase 2 （COX-2），

-human chorionic gonadotropin （

-HCG） and ACA were detected by enzyme-linked immunosorbent assay. The antibody-negative conversion rate was calculated， the clinical efficacy of the patient was observed， and the occurrence of adverse drug reactions was recorded.

RESULTS

After treatment， the pregnancy success rate and antibody-negative conversion rate of combination treatment group were significantly higher than those in the control group （

＜0.05）， and the abortion rate was significantly lower than that in the control group （

＜0.05）. Compared with before treatment， serum levels of IL-6， TNF-α and ACA in 2 groups were decreased significantly （

＜0.05）， while the levels of COX-2 and

-HCG were increased significantly （

＜0.05）； the changes of above indexes in combination treatment group were more significant（

＜0.05）. There was no statistical significance in the incidence of adverse drug reactions between 2 groups（

＞0.05）.

CONCLUSIONS

Gushen antai pills can maintain high expression of

-HCG， reduce the level of ACA and improve immune microenvironment in patients with ACA-positive recurrent abortion by increasing the serum level of COX-2 and decreasing the serum level of IL-6， so as to increase the success rate of pregnancy.

关键词

复发性流产：固肾安胎丸达肝素钠抗心磷脂抗体临床疗效

Keywords

Gushen antai pillheparin sodiumanticardiolipin antibodyclinical efficacy

references

YE M，FANG R，LUN S，et al. Effects of Gushen antai decoction on serum homocysteine and anticardiolipin antibodies levels in patients with unexplained recurrent spontaneous abortion[J]. Int J Clin Exp Med，2021，14（1）：340-346.

FAHIM F，BIN FAHIM W，LAKHTA G，et al. Anticardiolipin antibodies and lupus anticoagulant； prevalence in pregnant patients with recurrent miscarriages[J]. Am J Health Med Nurs Pract，2022，7（3）：8-15.

YU X M，HE L. Aspirin and heparin in the treatment of recurrent spontaneous abortion associated with antiphospholipid antibody syndrome：a systematic review and meta-analysis[J]. Exp Ther Med，2021，21（1）：57.

刘羽稀. 固肾安胎丸治疗子宫内膜薄性不孕症的临床疗效分析[J/OL]. 实用妇科内分泌电子杂志，2021，8（7）：74-76[2023-02-25]. https：//d.wanfangdata.com.cn/periodical/syfknfm-e202107022.DOI：10.16484/j.cnki.issn2095-8803.2021.07.008https://d.wanfangdata.com.cn/periodical/syfknfm-e202107022.DOI:10.16484/j.cnki.issn2095-8803.2021.07.008.

季清云，张丽，申小静，等. 孕康颗粒联合阿司匹林和低分子肝素钠治疗复发性流产的临床研究[J]. 现代药物与临床，2022，37（8）：1808-1812.

林其德，苏小玲. 抗磷脂抗体相关性复发性流产的诊治[J]. 中国实用妇科与产科杂志，2013，29（2）：106-108.

陈子江，林其德，王谢桐，等. 孕激素维持早期妊娠及防治流产的中国专家共识[J]. 中华妇产科杂志，2016，51（7）：481-483.

低分子肝素防治自然流产中国专家共识编写组. 低分子肝素防治自然流产中国专家共识[J]. 中华生殖与避孕杂志，2018，38（9）：701-708.

HUANG X Q，JU H R，SONG G H. Evaluation of basal hormone levels and androgen receptor gene mutations in individuals with recurrent abortion[J]. Cell Mol Biol，2022，67（4）：274-281.

YAO H Z，JI Y M，ZHOU Y R. Analysis of blood coagulation indexes，thromboelastogram and autoantibodies in patients with recurrent pregnancy loss[J]. Pak J Med Sci，2022，38（7）：2005-2010.

DEVREESE K M J，ZUILY S，MERONI P L. Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome[J]. J Transl Autoimmun，2021，4：100134.

LIU Z L，SUN S，XU H J，et al. Prognostic analysis of antibody typing and treatment for antiphospholipid syndrome-related recurrent spontaneous abortion[J]. Int J Gynaecol Obstet，2022，156（1）：107-111.

COOMARASAMY A，DHILLON-SMITH R K，PAPADOPOULOU A，et al. Recurrent miscarriage：evidence to accelerate action[J]. Lancet，2021，397（10285）：1675-1682.

YANG Z Y，SHEN X L，ZHOU C Q，et al. Prevention of recurrent miscarriage in women with antiphospholipid syndrome：a systematic review and network meta-analysis[J]. Lupus，2021，30（1）：70-79.

CAO X L，SONG J Y，ZHANG X X，et al. Effects of a Chinese patent medicine Gushen’antai pills on ongoing pregnancy rate of hormone therapy FET cycles：a multi-center，randomized，double-blind，placebo-controlled clinical trial[J]. Front Endocrinol （Lausanne），2020，11：581719.

杨敬敬，杨春丽，王宝金. 固肾安胎丸联合阿司匹林治疗复发性流产的临床研究[J]. 现代药物与临床，2019，34（4）：1100-1103.

史杨，马万增，冯延红，等. 固肾安胎丸辅助泼尼松及阿司匹林治疗不明原因复发性流产及对外周血免疫细胞、FDP、D-D影响[J]. 中国计划生育学杂志，2022，30（8）：1734-1739.

ZHOU W J，YANG H L，MEI J，et al. Fructose-1， 6-bisphosphate prevents pregnancy loss by inducing decidual COX-2+ macrophage differentiation[J]. Sci Adv，2022，8（8）：eabj2488.

CAO Y，JIA X T，HUANG Y J，et al. Vitamin D stimulates miR-26b-5p to inhibit placental COX-2 expression in preeclampsia[J]. Sci Rep，2021，11（1）：11168.

POURMOGHADAM Z，SOLTANI-ZANGBAR M S，SHEIKHANSARI G，et al. Intrauterine administration of autologous hCG-activated peripheral blood mononuclear cells improves pregnancy outcomes in patients with recurrent implantation failure： a double-blind，randomized control trial study[J]. J Reprod Immunol，2020，142：103182.

MIAO L，LU Q B. Anzi heji downregulates DNMT1 to improve anticardiolipin antibody （ACA）-positive abortion by regulating JAK/STAT pathway[J]. Nat Prod Commun，2022，17（7）：1934578X2211128.

XIE Y Z，LU Q B. Proteomic analysis of differentially expressed proteins in the placenta of anticardiolipin antibody- （ACA-） positive pregnant mice after anzi heji treatment[J]. Evid Based Complement Alternat Med，2020，2020：1967698.

HUA F，LI C H，WANG H，et al. Relationship between expression of COX-2，TNF-α，IL-6 and autoimmune-type recurrent miscarriage[J]. Asian Pac J Trop Med，2013，6（12）：990-994.

ELIEH ALI KOMI D，SHAFAGHAT F，HAIDL G. Significance of mast cells in spermatogenesis，implantation，pregnancy，and abortion：cross talk and molecular mechanisms[J]. Am J Reprod Immunol，2020，83（5）：e13228.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

雌激素+黄体素联合常规方案治疗女性绝经后骨质疏松症的效果观察

甘地胶囊辅助治疗糖尿病肾病的疗效观察

帕利哌酮与利培酮治疗精神分裂症的临床观察

醒脑静与盐酸纳洛酮治疗昏迷脑出血的临床观察

复方甲氧那明联合孟鲁司特钠治疗感染后咳嗽的临床观察

Related Author

WANG Feng

LI Zhenwu

YAN Ruifeng

LI Zhian

WEI Xin

YAO Huijuan

LIU Yan

ZHANG Jian

Related Institution

No data

Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰